Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Aug 8, 2013 · 10-Q · 39 days after period end · 0001193125-13-325439
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | -$19.05M | $8.04M | $1.28M | -$16.66M |
| EPS Diluted | -$0.60 | $0.35 | $0.06 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 8, 2013 · 39 d after period end
